1887

Abstract

Drug resistant tuberculosis remains a worldwide problem that requires prompt diagnosis.

The WHO recommended direct, rapid Xpert MTB/RIF is prohibitively costly, therefore, there is a need to validate a rapid, affordable DST for use in low- and middle-income settings.

The technical performance and time to results of a simple, direct microscopy-based slide DST (SDST) assay for diagnosis of rifampicin-resistant TB was evaluated in Uganda.

Sputum samples from 122 smear-positive re-treatment TB patients presenting to the TB treatment centre at Uganda’s National Referral Hospital, Mulago, Kampala, Uganda were examined. The sputum samples were tested by the direct SDST which was compared to the indirect Lowenstein Jensen Proportion Method (LJDST) method as the gold standard. The time to results was defined as the time from DST setting to results interpretation. The results were further analysed for sensitivity and specificity as well as agreement between LJDST and SDST for rifampicin resistance determination.

A total of 117 smear positive sputum samples with valid results for both tests were compared. The median time to results for SDST was 14 days with an interquartile range (IQR) of 10–14 days compared to 60 days with IQR of 60–75 days for LJDST. The number for rifampicin resistance by the gold standard LJDST was 26. The SDST had a sensitivity of 96 % (95 %; CI 81–99 %) and a specificity of 97.8 % (95 %; CI 93–100 %). The Positive Predictive and Negative Predictive values for SDST were 92.3 % (95 %; CI 76.8–99 %) and 98.9 % (95 %; CI 94–100 %), respectively. The agreement between SDST and LJDST was 92.3 %.

The SDST was found to be a rapid and accurate direct test for the detection of rifampicin resistance among retreatment TB cases in low-income settings.

Funding
This study was supported by the:
  • National Institutes of Health (Award D43TW010132)
    • Principle Award Recipient: WillySsengooba
  • European and Developing Countries Clinical Trials Partnership (Award TMA2018CDF-2351)
    • Principle Award Recipient: WillySsengooba
  • Makerere University (UG) Research and Innovations
    • Principle Award Recipient: BeatriceAchan
  • National Institutes of Health (Award D43TW010132)
    • Principle Award Recipient: BeatriceAchan
  • European and Developing Countries Clinical Trials Partnership (Award TMA2018CDF-2371)
    • Principle Award Recipient: BeatriceAchan
  • DAAD In-country (Uganda) Postgraduate scholarship (Award Not given)
    • Principle Award Recipient: BeatriceAchan
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001331
2021-02-24
2021-10-17
Loading full text...

Full text loading...

References

  1. WHO Global Tuberculosis Report, Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2018
    [Google Scholar]
  2. Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009; 9:67 [View Article][PubMed]
    [Google Scholar]
  3. Aziz MA, Wright A. The world health Organization/International Union against tuberculosis and lung disease global project on surveillance for anti-tuberculosis drug resistance: a model for other infectious diseases. Clin Infect Dis 2005; 41 Suppl 4:S258–S262 [View Article][PubMed]
    [Google Scholar]
  4. WHO World Health Organization; Tuberculosis diagnostics, Xpert MTB/RIF Test. WHO Recommendations October 2013; Available: http://www.who.int/tb/publications/Xpert_factsheet.pdf?ua=1. Accessed Aug 1 2014. 2014..
  5. WHO Guidelines for Surveillance of Drug Resistance in Tuberculosis, 5th ed. 2015
    [Google Scholar]
  6. Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol 2011; 49:4138–4141 [View Article][PubMed]
    [Google Scholar]
  7. Hamid Salim A, Aung KJM, Hossain MA, Van Deun A. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB. Int J Tuberc Lung Dis 2006; 10:1248–1254[PubMed]
    [Google Scholar]
  8. Noor R, Hossain A, Munshi SK, Rahman F, Kamal SMM. Slide drug susceptibility test for the detection of multidrug-resistant tuberculosis in Bangladesh. J Infect Chemother 2013; 19:818–824 [View Article][PubMed]
    [Google Scholar]
  9. Carley S, Dosman S, Jones SR, Harrison M. Simple nomograms to calculate sample size in diagnostic studies. Emerg Med J 2005; 22:180–181 [View Article][PubMed]
    [Google Scholar]
  10. Kent PT, Kubica GP. Public health mycobacteriology -a guide for the level III laboratory. US. Department of Health and Human Services, Washington, D.C 1985; 1985:
    [Google Scholar]
  11. Aziz MA, Laszlo A, Raviglione M, Rieder H, Espinal M et al. Guidelines for Surveillance of Drug Resistance in Tuberculosis, 2nd ed. World Health Organization. Document WHO/CDS/CSR/RMD/2003.; 2003). eds
    [Google Scholar]
  12. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6:31 [View Article][PubMed]
    [Google Scholar]
  13. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159–174 [View Article][PubMed]
    [Google Scholar]
  14. Dickinson JM, Allen BW, Mitchison DA. Slide culture sensitivity tests. Tubercle 1989; 70:115–121 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001331
Loading
/content/journal/jmm/10.1099/jmm.0.001331
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error